Scholarlink

Background <p>Ablative fractional carbon dioxide (AFCO<sub>2</sub>) laser therapy is used for treating pathological scarring. However, mechanisms underlying reduction in hypertrophic scarring are poorly understood.</p> Methods <p>We investigated cellular mechanisms of AFCO<sub>2</sub> laser therapy by performing single-cell RNA sequencing (scRNA-seq) on skin biopsies from burn survivors with hypertrophic scars before and after three sessions of AFCO<sub>2</sub> therapy. Scar reduction was assessed subjectively and objectively.</p> Results <p>Those with a good response (GR) to laser therapy have scars less than 6 years from injury, whereas poor responders (PR) have scars over 6 years since injury. ScRNA-seq analysis of skin biopsies reveals that genes enriched in GR are associated with extracellular matrix and structure organisation (<i>COL14A1</i>, <i>POSTN</i>, <i>SPARC</i>); whereas genes enriched in PR are related to enhanced immune inflammatory responses (<i>CXCL14, JUN, TNC</i>). Notably, expression of the pro-fibrotic gene Engrailed-1 (<i>EN1</i>) remains elevated in PR scars compared to GR. The ECM-regulatory gene <i>TIMP-1</i> (Tissue Inhibitor of Metalloproteinases 1) is also significantly upregulated in PR scars following treatment relative to GR scars, although at the protein level TIMP1 levels decrease in PR but increase in GR after therapy. The regenerative-associated gene, <i>TRPS1</i> (Transcriptional Repressor GATA Binding 1) expression demonstrates opposing regulation post treatment, with upregulation observed in GR scars but downregulation in PR scars, underscoring distinct transcriptional trajectories associated with differential therapeutic outcomes. Finally, distinct intercellular communication networks and differentiation trajectories are observed after AFCO<sub>2</sub>, with regenerative mesenchymal fibroblasts predominating in GR but inflammatory fibroblasts associated with PR.</p> Conclusions <p>We conclude AFCO<sub>2</sub> laser therapy is more effective if done early after injury and distinct fibroblast recruitment is associated with a good response, specifically regenerative fibroblasts.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Cellular heterogeneity in hypertrophic burn scars in response to carbon dioxide laser therapy

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月10日

查看全文
  • Yung-Yi Chen,
  • Christopher Mahony,
  • Jason Turner,
  • Charlotte G. Smith,
  • Abdulrazak Abdulsalam,
  • Ezekwe Amirize,
  • Amberley Prince,
  • Adrian Heagerty,
  • Claudia Roberts,
  • Adam Croft,
  • Yvonne Wilson,
  • Naiem Moiemen,
  • Janet M. Lord

摘要

Background

Ablative fractional carbon dioxide (AFCO2) laser therapy is used for treating pathological scarring. However, mechanisms underlying reduction in hypertrophic scarring are poorly understood.

Methods

We investigated cellular mechanisms of AFCO2 laser therapy by performing single-cell RNA sequencing (scRNA-seq) on skin biopsies from burn survivors with hypertrophic scars before and after three sessions of AFCO2 therapy. Scar reduction was assessed subjectively and objectively.

Results

Those with a good response (GR) to laser therapy have scars less than 6 years from injury, whereas poor responders (PR) have scars over 6 years since injury. ScRNA-seq analysis of skin biopsies reveals that genes enriched in GR are associated with extracellular matrix and structure organisation (COL14A1, POSTN, SPARC); whereas genes enriched in PR are related to enhanced immune inflammatory responses (CXCL14, JUN, TNC). Notably, expression of the pro-fibrotic gene Engrailed-1 (EN1) remains elevated in PR scars compared to GR. The ECM-regulatory gene TIMP-1 (Tissue Inhibitor of Metalloproteinases 1) is also significantly upregulated in PR scars following treatment relative to GR scars, although at the protein level TIMP1 levels decrease in PR but increase in GR after therapy. The regenerative-associated gene, TRPS1 (Transcriptional Repressor GATA Binding 1) expression demonstrates opposing regulation post treatment, with upregulation observed in GR scars but downregulation in PR scars, underscoring distinct transcriptional trajectories associated with differential therapeutic outcomes. Finally, distinct intercellular communication networks and differentiation trajectories are observed after AFCO2, with regenerative mesenchymal fibroblasts predominating in GR but inflammatory fibroblasts associated with PR.

Conclusions

We conclude AFCO2 laser therapy is more effective if done early after injury and distinct fibroblast recruitment is associated with a good response, specifically regenerative fibroblasts.